Peer-reviewed research on tesamorelin consistently confirms its mechanism as a growth hormone secretagogue with targeted effects on visceral adiposity, making it distinct from general fat loss agents
Patients with MTHFR gene variants experience GI side effects more intensely and benefit from methylated B vitamin co-supplementation during the adaptation phase
Original publication: Rosenstock J, Allison D, Birkenfeld AL, Blicher TM, Deenadayalan S, Jacobsen JB, Serusclat P, Violante R, Watada H, Davies M
State-by-state regulatory variability adds further uncertainty, especially as some jurisdictions may approach these treatments differently, much like cannabis regulations
For example, Arg17 and Arg18 of oxyntomodulin form interactions with the ECD and top of TM2 in the simulations, whereas the corresponding alanine residues in GLP-1 could not form these interactions